Andrei Blasko

Andrei Blasko, Ph.D., FRSC, is a Senior Fellow at Novartis Pharmaceuticals Corp. working in Inhalation Technical Development. He is also member of the Editorial Board of the American Journal of Advanced Drug Delivery. Previously Dr. Blasko was Director of Analytical Method Development and co-lead a Drug Discovery & CMC Development program at Pain Therapeutics, Inc., where he managed projects in drug discovery, structural biology, and analytical method development up to NDA submission. Other companies include Celera, Pfizer/Pharmacia/Sugen and Roche Bioscience. Dr. Blasko is a Fellow of the Royal Society of Chemistry and a member of ACS, AAPS and FIP.